These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38447274)

  • 21. Transplacental transfer of maternal respiratory syncytial virus (RSV) antibody and protection against RSV disease in infants in rural Nepal.
    Chu HY; Tielsch J; Katz J; Magaret AS; Khatry S; LeClerq SC; Shrestha L; Kuypers J; Steinhoff MC; Englund JA
    J Clin Virol; 2017 Oct; 95():90-95. PubMed ID: 28903080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of concurrent bacterial infection in preterm infants hospitalized due to respiratory syncytial virus infection.
    Resch B; Gusenleitner W; Mueller WD
    Acta Paediatr; 2007 Apr; 96(4):495-8. PubMed ID: 17326757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evolutionary analysis of the ON1 genotype of subtype a respiratory syncytial virus in Riyadh during 2008-16.
    Al-Hassinah S; Parveen S; Somily AM; AlSaadi MM; Alamery SF; Haq SH; Alsenaidy HA; Ahmed A
    Infect Genet Evol; 2020 Apr; 79():104153. PubMed ID: 31881360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants.
    Griffin MP; Yuan Y; Takas T; Domachowske JB; Madhi SA; Manzoni P; Simões EAF; Esser MT; Khan AA; Dubovsky F; Villafana T; DeVincenzo JP;
    N Engl J Med; 2020 Jul; 383(5):415-425. PubMed ID: 32726528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical relevance of prevention of respiratory syncytial virus lower respiratory tract infection in preterm infants born between 33 and 35 weeks gestational age.
    Carbonell-Estrany X; Bont L; Doering G; Gouyon JB; Lanari M
    Eur J Clin Microbiol Infect Dis; 2008 Oct; 27(10):891-9. PubMed ID: 18629558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
    Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
    Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Chronologic Age and Young Child Exposure on Respiratory Syncytial Virus Disease among US Preterm Infants Born at 32 to 35 Weeks Gestation.
    Simões EA; Anderson EJ; Wu X; Ambrose CS
    PLoS One; 2016; 11(11):e0166226. PubMed ID: 27898687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for hospitalisation due to respiratory syncytial virus infection in children receiving prophylactic palivizumab.
    Chida-Nagai A; Sato H; Sato I; Shiraishi M; Sasaki D; Izumi G; Yamazawa H; Cho K; Manabe A; Takeda A
    Eur J Pediatr; 2022 Feb; 181(2):539-547. PubMed ID: 34417646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of respiratory syncytial virus A and B and parainfluenzavirus 3 sequences in respiratory tracts of infants by a single PCR with primers targeted to the L-polymerase gene and differential hybridization.
    Eugene-Ruellan G; Freymuth F; Bahloul C; Badrane H; Vabret A; Tordo N
    J Clin Microbiol; 1998 Mar; 36(3):796-801. PubMed ID: 9508315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prophylaxis for respiratory syncytial virus with respiratory syncytial virus-immunoglobulin intravenous among preterm infants of thirty-two weeks gestation and less: reduction in incidence, severity of illness and cost.
    Atkins JT; Karimi P; Morris BH; McDavid G; Shim S
    Pediatr Infect Dis J; 2000 Feb; 19(2):138-43. PubMed ID: 10694001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Respiratory syncytial virus (RSV) infection in preterm infants and the protective effects of RSV immune globulin (RSVIG). Respiratory Syncytial Virus Immune Globulin Study Group.
    Groothuis JR; Simoes EA; Hemming VG
    Pediatrics; 1995 Apr; 95(4):463-7. PubMed ID: 7700741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe Respiratory Syncytial Virus Infection in Preterm Infants and Later Onset of Asthma.
    Jalink MB; Langley JM; Dodds L; Andreou P
    Pediatr Infect Dis J; 2019 Nov; 38(11):1121-1125. PubMed ID: 31425330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of potential immune/diagnosis related gene-immunocyte subtype networks in extracellular immune response to respiratory syncytial virus infection.
    Wang B; Liu H
    Virus Res; 2022 Nov; 321():198906. PubMed ID: 36044931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune Profiling of Cord Blood From Preterm and Term Infants Reveals Distinct Differences in Pro-Inflammatory Responses.
    Anderson J; Thang CM; Thanh LQ; Dai VTT; Phan VT; Nhu BTH; Trang DNX; Trinh PTP; Nguyen TV; Toan NT; Harpur CM; Mulholland K; Pellicci DG; Do LAH; Licciardi PV
    Front Immunol; 2021; 12():777927. PubMed ID: 34790206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Respiratory syncytial virus risk factors in late preterm infants.
    Lanari M; Silvestri M; Rossi GA
    J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():102-7. PubMed ID: 19925369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors and incidence of hospitalization due to respiratory syncytial virus (RSV)-associated lower respiratory tract infection (LRTI) in non-prophylaxed moderate-to-late preterm infants in Bosnia and Herzegovina.
    Maksić H; Heljić S; Skokić F; Šumanović-Glamuzina D; Milošević V; Zlatanović A; Gerard N
    Bosn J Basic Med Sci; 2018 Aug; 18(3):279-288. PubMed ID: 29750895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular characterization of respiratory syncytial viruses circulating in a paediatric cohort in Amman, Jordan.
    Trovão NS; Khuri-Bulos N; Tan Y; Puri V; Shilts MH; Halpin RA; Fedorova NB; Nelson MI; Halasa N; Das SR
    Microb Genom; 2021 Jun; 7(6):. PubMed ID: 31532357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infant respiratory syncytial virus prophylaxis and nasopharyngeal microbiota until 6 years of life: a subanalysis of the MAKI randomised controlled trial.
    Man WH; Scheltema NM; Clerc M; van Houten MA; Nibbelke EE; Achten NB; Arp K; Sanders EAM; Bont LJ; Bogaert D
    Lancet Respir Med; 2020 Oct; 8(10):1022-1031. PubMed ID: 32203712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new cost-utility analysis assessing risk factor-guided prophylaxis with palivizumab for the prevention of severe respiratory syncytial virus infection in Italian infants born at 29-35 weeks' gestational age.
    Keary IP; Ravasio R; Fullarton JR; Manzoni P; Lanari M; Paes BA; Carbonell-Estrany X; Baraldi E; Tarride JÉ; Rodgers-Gray B
    PLoS One; 2023; 18(8):e0289828. PubMed ID: 37561741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An outbreak of RSV infections in a neonatology clinic during the RSV-season.
    Vakrilova L; Nikolova SH; Slavov S; Radulova P; Slancheva B
    BMC Pediatr; 2021 Dec; 21(1):567. PubMed ID: 34895173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.